Clinical Trial Update: Stroke Minimization Through Additive Anti-atherosclerotic Agents in Routine Treatment II Study (SMAART II) [Phase 3]

View source ↗

Summary

Clinical trial update for SMAART II, a Phase 3 study evaluating additive anti-atherosclerotic therapy for stroke in routine treatment. The study status is not y…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Snippet

Sponsor: Northern California Institute of Research and Education | Conditions: Stroke, Medication Adherence | Phase 3 | Status: NOT_YET_RECRUITING